May 1 (Reuters) - Forward Pharma A/S FWP.O -
* Forward Pharma further aligns cost structure with focus
following settlement and license agreement
* Forward Pharma A/S - chief financial officer Joel Sendek
has left company, effective april 30, 2017
* Forward Pharma A/S - executive vice presidents rupert
sandbrink and andrzej stano will be leaving company in q3 of
2017
* FORWARD PHARMA- some non-executive roles primarily in
research and development to be made redundant, with goal of
reducing total number of full-time employees to below 7
Source text for Eikon: ID:nGNXNUOEIa
Further company coverage: FWP.O
((bangalore.newsroom@thomsonreuters.com;))